Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-09

Clinical Trial Update: Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH Delivered From a Iontophoretic Patch Compared to Oral Treatment With Clomiphene or Placebo in Infertile Females [Phase 2]

View source ↗

Summary

Phase 2 clinical trial completed evaluating three dosage strengths of a pulsatile GnRH iontophoretic patch. The patch was compared to oral clomiphene or placebo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOMIPHENE CITRATE (CLOMIPHENE CITRTAE)
  • Pulsatile GnRH iontophoretic patch (gonadotropin-releasing hormone)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Infertility | Phase 2 | Status: COMPLETED